Company intelligence / Profile preview

Tomorrowlabs

Ownership: Private
Development stage: Other

Overview

Tomorrowlabs has developed and commercialized a line of skincare and haircare products based on its proprietary HSF technology. Clinical studies published by the company report significant improvements in skin rejuvenation—visual rejuvenation equivalent to up to ~2.8 years after six weeks—and reduction in hereditary hair loss after twelve weeks, with results published in peer-reviewed medical journals and validated by dermatologists and plastic surgeons.

Therapeutic areas: Dermatology
Modalities: Small moleculePeptidesProtein
Industry: Non-Drug Biotech

Partnerships

Collaborations with leading medical universities and research institutes for clinical validation; specific partners not named publicly

Beyond the preview

Go deeper on Tomorrowlabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tomorrowlabs.

Explore the full profile